Publikationsansicht

P18-12 LB. Phase I clinical trial with a new recombinant MVA-BN®-multiantigen vaccine: high responder rate and considerable breadth of immunological response

Details der Publikation
Download http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2767928
Herausgeber BioMed Central
Archiv PubMed Central (PMC3 - NLM DTD) (United States)
Keywords Poster Presentation
Typ Text
Sprache Englisch